{"id":"omeprazol","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":["Acute nephropathy","Atrophic gastritis","Chronic heart failure","Disease of liver","Edema","Fracture of bone","Hepatic failure","Hypomagnesemia","Oliguria","Osteoporosis"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"trials":[],"_chembl":null,"aliases":["Prilosec, Losec"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":{"setId":"a19ce586-59b7-4c2e-9e8d-12e8f0f058e2","title":"OMEPRAZOLE CAPSULE, DELAYED RELEASE [REMEDYREPACK INC.]"},"ecosystem":[],"mechanism":{"target":"ATP-binding cassette sub-family G member 2, Cytochrome P450 1A2, Cytochrome P450 2C19"},"_scrapedAt":"2026-03-27T23:58:16.781Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Duodenal Ulcer due to H. Pylori","diseaseId":"duodenal-ulcer-due-to-h.-pylori","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Duodenal ulcer disease","diseaseId":"duodenal-ulcer-disease","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Erosive esophagitis","diseaseId":"erosive-esophagitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Gastric Hypersecretory Conditions","diseaseId":"gastric-hypersecretory-conditions","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Gastric ulcer","diseaseId":"gastric-ulcer","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Gastroesophageal reflux disease","diseaseId":"gastroesophageal-reflux-disease","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Maintenance of Healing Erosive Esophagitis","diseaseId":"maintenance-of-healing-erosive-esophagitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Pathological Gastric Hypersecretory Condition","diseaseId":"pathological-gastric-hypersecretory-condition","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Peptic reflux disease","diseaseId":"peptic-reflux-disease","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Peptic ulcer","diseaseId":"peptic-ulcer","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Reduction of risk of upper gastrointestinal bleeding","diseaseId":"reduction-of-risk-of-upper-gastrointestinal-bleeding","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Zollinger-Ellison syndrome","diseaseId":"zollinger-ellison-syndrome","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT07223671","phase":"PHASE1","title":"Study to Evaluate the Effect of Repotrectinib on the Drug Levels of Transporter and CYP P450 Probe Substrates in Healthy Adult Participants","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2025-12-31","conditions":"Healthy Volunteers","enrollment":30},{"nctId":"NCT07487142","phase":"PHASE3","title":"Prevalence of Asymptomatic H Pylori Infection Among Patients Undergoing PCI and Impact of Its Eradication on Occurrence of GIT Symptoms and Bleeding\"","status":"COMPLETED","sponsor":"Beni-Suef University","startDate":"2024-06-10","conditions":"H Pylori Infection","enrollment":121},{"nctId":"NCT07312370","phase":"PHASE4","title":"Esomeprazole Plus Sucralfate for Post-ESD Ulcer Healing","status":"NOT_YET_RECRUITING","sponsor":"LanZhou University","startDate":"2026-04-20","conditions":"Early Gastric Cancer, Gastric Dysplasia, Gastric Neoplasms","enrollment":120},{"nctId":"NCT04337580","phase":"PHASE2","title":"Fatty Acid Synthase Inhibition in Castration Refractory Prostate Cancer","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2021-03-05","conditions":"Prostate Cancer, Refractory Cancer, Castration Resistant Prostatic Cancer","enrollment":50},{"nctId":"NCT05799105","phase":"PHASE4","title":"OPEN Versus InTact Capsule Proton Pump Inhibitors for the Treatment of Marginal Ulcers","status":"RECRUITING","sponsor":"Stephen Firkins","startDate":"2023-03-14","conditions":"Marginal Ulcer","enrollment":122},{"nctId":"NCT05582174","phase":"PHASE4","title":"PPI Infusion Versus Oral Acid Pump Inhibitors for Bleeding Peptic Ulcers","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2023-05-18","conditions":"Upper GI Bleeding, Proton Pump Inhibitors","enrollment":594},{"nctId":"NCT06562907","phase":"PHASE1","title":"Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM)","status":"RECRUITING","sponsor":"Gilead Sciences","startDate":"2024-08-28","conditions":"Weight Management","enrollment":134},{"nctId":"NCT06378398","phase":"EARLY_PHASE1","title":"A Trial of Omeprazole and Low Dose Aspirin to Identify Colorectal Biomarkers of Preventive Efficacy","status":"COMPLETED","sponsor":"University of Michigan Rogel Cancer Center","startDate":"2024-06-14","conditions":"Colorectal Neoplasia","enrollment":21},{"nctId":"NCT02592317","phase":"PHASE1","title":"A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Aragon Pharmaceuticals, Inc.","startDate":"2016-02-12","conditions":"Prostatic Neoplasms, Castration-Resistant","enrollment":23},{"nctId":"NCT06566794","phase":"NA","title":"KF2022#4-trial: Effects of a Beta Blocker and NSAID on CYP Mediated Drug Metabolism","status":"COMPLETED","sponsor":"Helsinki University Central Hospital","startDate":"2024-08-22","conditions":"Drug Interaction","enrollment":12},{"nctId":"NCT06953986","phase":"NA","title":"A Randomized, Three-Arm Study Comparing Vonaprazan 10 mg, Vonaprazan 20 mg, and Esomeprazole 40 mg for the Healing of LA Grade B or Higher Reflux Esophagitis at 8 Weeks","status":"RECRUITING","sponsor":"Asian Institute of Gastroenterology, India","startDate":"2025-12-20","conditions":"GERD","enrollment":414},{"nctId":"NCT07214662","phase":"PHASE1","title":"A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-0587 as a Monotherapy and in Combination With Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer","status":"RECRUITING","sponsor":"Genentech, Inc.","startDate":"2026-01-13","conditions":"Breast Cancer","enrollment":136},{"nctId":"NCT03553563","phase":"PHASE3","title":"A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal Ulcer","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2018-07-24","conditions":"Reflux Esophagitis, Gastric Ulcer, Duodenal Ulcer","enrollment":50},{"nctId":"NCT06943794","phase":"NA","title":"Eradication of Helicobacter Pylori Subtypes at High Gastric Cancer Risk: a Cluster-randomized Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"Fudan University","startDate":"2026-03-30","conditions":"Gastric (Stomach) Cancer","enrollment":4824},{"nctId":"NCT07426042","phase":"PHASE1","title":"Effect of Dexamethasone on CYP Enzyme Activity in Healthy Male Subjects","status":"NOT_YET_RECRUITING","sponsor":"Min Kyu Park","startDate":"2026-04","conditions":"Drug-Drug Interactions","enrollment":12},{"nctId":"NCT07235748","phase":"PHASE1","title":"Drug-drug Interaction Study of Vorasidenib With Bupropion, Repaglinide, Flurbiprofen, Omeprazole, Midazolam, and Rosuvastatin in Healthy Adult Participants","status":"COMPLETED","sponsor":"Institut de Recherches Internationales Servier (I.R.I.S.)","startDate":"2025-10-07","conditions":"Healthy Adult Participants","enrollment":28},{"nctId":"NCT07293910","phase":"PHASE2","title":"Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection","status":"RECRUITING","sponsor":"Tanta University","startDate":"2026-02-15","conditions":"HELICOBACTER PYLORI INFECTIONS, Helicobacter Infection, Helicobacter Pylori Gastrointestinal Tract Infection","enrollment":66},{"nctId":"NCT07399054","phase":"","title":"Efficacy and Safety of Esomeprazole 40 mg IV in Post-Surgical Patients Admitted to the ICU","status":"NOT_YET_RECRUITING","sponsor":"Asian Institute of Gastroenterology, India","startDate":"2026-01-15","conditions":"Stress Ulcers, Reflux Episodes","enrollment":50},{"nctId":"NCT06930872","phase":"PHASE1","title":"Drug Interaction Study of ZYN002 Transdermal Gel and Probe Substrates","status":"COMPLETED","sponsor":"Harmony Biosciences Management, Inc.","startDate":"2025-06-06","conditions":"Drug Interaction","enrollment":29},{"nctId":"NCT07142486","phase":"NA","title":"Effects of Omeprazole Ingestion on Postprandial Amino Acid Concentrations in Response to a Mixed Meal","status":"RECRUITING","sponsor":"McGill University","startDate":"2025-09-01","conditions":"Digestive Health, Gastrointestinal Health","enrollment":4},{"nctId":"NCT05646862","phase":"PHASE3","title":"A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2023-06-07","conditions":"Breast Cancer","enrollment":420},{"nctId":"NCT06717269","phase":"PHASE1","title":"Relative Bioavailability of NX-5948 Tablets vs Capsules and the Effect of Covariates on the PK of NX-5948 Tablets","status":"RECRUITING","sponsor":"Nurix Therapeutics, Inc.","startDate":"2024-11-30","conditions":"Healthy Volunteer","enrollment":18},{"nctId":"NCT06686628","phase":"PHASE1","title":"An Open-label, DDI Study to Investigate the Effects of Amlitelimab on the PK of Selected Cytochrome P450 Substrates","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sanofi","startDate":"2024-11-20","conditions":"Dermatitis Atopic","enrollment":23},{"nctId":"NCT03947385","phase":"PHASE1, PHASE2","title":"Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions","status":"RECRUITING","sponsor":"IDEAYA Biosciences","startDate":"2019-06-28","conditions":"Metastatic Uveal Melanoma, Cutaneous Melanoma, Colorectal Cancer","enrollment":336},{"nctId":"NCT06510010","phase":"PHASE2","title":"Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer","status":"RECRUITING","sponsor":"Sixth Affiliated Hospital, Sun Yat-sen University","startDate":"2024-12-31","conditions":"Chemotherapy Effect","enrollment":198},{"nctId":"NCT06393868","phase":"PHASE3","title":"Reducing Gastrointestinal Bleeding With Proton Pump Inhibitor Therapy in Acute Venous Thromboembolism","status":"RECRUITING","sponsor":"Ottawa Hospital Research Institute","startDate":"2024-11-06","conditions":"Venous Thromboembolism, Gastro Intestinal Bleeding, Blood Clot","enrollment":360},{"nctId":"NCT05647278","phase":"PHASE4","title":"Tegoprazan-Amoxicillin Dual Therapy vs. Bismuth Quadruple Therapy for H. Pylori Infection (TATH-1)","status":"COMPLETED","sponsor":"Zhang Xiaofeng,MD","startDate":"2023-11-01","conditions":"Helicobacter Pylori Infection","enrollment":370},{"nctId":"NCT07326904","phase":"PHASE3","title":"Study Comparing Fexuprazan and Esomeprazole in Patients With Gastroesophageal Reflux Disease","status":"COMPLETED","sponsor":"Indonesia University","startDate":"2024-09-23","conditions":"Gastro Oesophageal Reflux Disease","enrollment":145},{"nctId":"NCT05517928","phase":"NA","title":"A Study to Evaluate the Impact of Lactobacillus Rhamnosus GG on Proton Pump Inhibitor-Induced Gut Dysbiosis","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2023-03-03","conditions":"Healthy","enrollment":30},{"nctId":"NCT04930991","phase":"EARLY_PHASE1","title":"High Dose Omeprazole in Patients With Pancreatic Cancer","status":"RECRUITING","sponsor":"University of Oklahoma","startDate":"2021-09-07","conditions":"Exocrine Pancreatic Cancer","enrollment":60},{"nctId":"NCT07294846","phase":"PHASE1","title":"Drug Interaction Study on Linaprazan Glurate Capsules","status":"COMPLETED","sponsor":"Jiangsu Sinorda Biomedicine Co., Ltd","startDate":"2025-09-08","conditions":"Healthy Volunteers, Patients","enrollment":56},{"nctId":"NCT07312721","phase":"PHASE4","title":"Comparative Effectiveness of Triple Versus Quadruple Therapy in the Treatment of Helicobacter Pylori Induced Gastritis","status":"COMPLETED","sponsor":"Azfar Farogh","startDate":"2024-01-05","conditions":"Helicobacter Pylori Infection, Chronic Gastritis, Peptic Ulcer Disease","enrollment":752},{"nctId":"NCT07269756","phase":"PHASE1","title":"A Study to Evaluate the Drug Interactions of HRS-7535 With Acetaminophen, Digoxin, Rosuvastatin, and Omeprazole in Obese or Overweight Subjects","status":"RECRUITING","sponsor":"Shandong Suncadia Medicine Co., Ltd.","startDate":"2025-12-08","conditions":"Obesity, Overweight","enrollment":40},{"nctId":"NCT07275827","phase":"PHASE3","title":"Comparative Study Evaluating Safety and Effectiveness of ( Proton Pump Inhibitor Versus Vonoprazan ) Based Triple Therapy With or Without Zinc to Eradicate H. Pylori Infection","status":"NOT_YET_RECRUITING","sponsor":"Tanta University","startDate":"2026-02-01","conditions":"HELICOBACTER PYLORI INFECTIONS","enrollment":88},{"nctId":"NCT07268820","phase":"PHASE4","title":"Heartburn, Gastroesophageal Reflux Disease","status":"RECRUITING","sponsor":"Incheon St.Mary's Hospital","startDate":"2025-07-07","conditions":"GERD","enrollment":160},{"nctId":"NCT05891119","phase":"EARLY_PHASE1","title":"Study to Investigate the Effect of Rocatinlimab (AMG 451) on the Pharmacokinetics of Multiple Cytochrome P450 (CYP450) Substrates in Participants With Moderate to Severe Atopic Dermatitis","status":"COMPLETED","sponsor":"Amgen","startDate":"2023-06-03","conditions":"Atopic Dermatitis","enrollment":21},{"nctId":"NCT05845645","phase":"PHASE1","title":"A Study to Test Bioavailability of of 2 New Formulations of UCB0599 in Healthy Participants in Part A and to Test Safety, Tolerability, and Pharmacokinetic (PK) of UCB0599 in Healthy Japanese and Chinese Participants in Part B","status":"COMPLETED","sponsor":"UCB Biopharma SRL","startDate":"2023-05-31","conditions":"Healthy Study Participants","enrollment":73},{"nctId":"NCT05822544","phase":"PHASE1","title":"Phase 1/1b Study of TLC-6740 in Healthy Subjects and Subjects With Obesity, With or Without Diabetes","status":"RECRUITING","sponsor":"OrsoBio, Inc","startDate":"2023-04-22","conditions":"Healthy Subjects, Obesity, Type 2 Diabetes","enrollment":564},{"nctId":"NCT06733675","phase":"PHASE1","title":"Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination","status":"RECRUITING","sponsor":"Basilea Pharmaceutica","startDate":"2025-01-07","conditions":"Healthy Volunteer, Pharmacokinetics, Safety","enrollment":46},{"nctId":"NCT07104318","phase":"PHASE3","title":"Personalized vs Standard of Care Treatment for Helicobacter Pylori Eradication Among Veterans","status":"NOT_YET_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2026-04-01","conditions":"Helicobacter Pylori","enrollment":360},{"nctId":"NCT05444556","phase":"PHASE1","title":"A Study of Imlunestrant (LY3484356) in Female Healthy Participants","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2022-07-07","conditions":"Healthy","enrollment":113},{"nctId":"NCT07068841","phase":"PHASE1","title":"Pharmacokinetic Effect of Y-3 on Repaglinide，Warfarin and Omeprazole in Healthy Participants","status":"COMPLETED","sponsor":"Neurodawn Pharmaceutical Co., Ltd.","startDate":"2025-05-18","conditions":"Pharmacokinetic Profiles, Y-3 for Injection, Drug-drug Interaction","enrollment":24},{"nctId":"NCT04840888","phase":"PHASE1","title":"A Study of LY3484356 in Healthy Female Participants","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2021-04-26","conditions":"Healthy","enrollment":82},{"nctId":"NCT02950259","phase":"PHASE1","title":"Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC)","status":"COMPLETED","sponsor":"Providence Health & Services","startDate":"2017-02-09","conditions":"Breast Neoplasm, Breast Neoplasm, Male, Triple Negative Breast Cancer","enrollment":16},{"nctId":"NCT07139366","phase":"PHASE4","title":"Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment","status":"RECRUITING","sponsor":"Yongquan Shi","startDate":"2025-10-28","conditions":"Gastritis, Dyspepsia, Helicobacter Pylori Infection","enrollment":1248},{"nctId":"NCT07259330","phase":"PHASE1","title":"To Determine the Effect of CYP Induction Following Administration of Nirogacestat in Healthy Adult Male Participants","status":"RECRUITING","sponsor":"SpringWorks Therapeutics, Inc.","startDate":"2025-11-17","conditions":"Healthy","enrollment":16},{"nctId":"NCT06494761","phase":"PHASE1","title":"A Study in Healthy Men to Test Whether Zongertinib Affects How 3 Other Medicines (Midazolam, Omeprazole, and Repaglinide) Are Taken up and Processed by the Body","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2024-07-30","conditions":"Healthy","enrollment":16},{"nctId":"NCT07156201","phase":"PHASE1","title":"A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ABS-1230 Given Orally Compared With Placebo in Healthy Participants Aged 18 to 55 Years","status":"RECRUITING","sponsor":"Actio Biosciences, Inc.","startDate":"2025-08-28","conditions":"KCNT1-Related Epilepsy","enrollment":74},{"nctId":"NCT07018635","phase":"PHASE1","title":"A Study to Assess the Effect of Itraconazole, Rifampin, and Acid-Reducing Agents on INCB161734 Pharmacokinetics When Administered Orally in Healthy Participants","status":"COMPLETED","sponsor":"Incyte Corporation","startDate":"2025-07-16","conditions":"Healthy Participants","enrollment":63},{"nctId":"NCT06255886","phase":"PHASE4","title":"Treatment of Gastroesophageal Reflux Disease in Infants","status":"RECRUITING","sponsor":"Odense University Hospital","startDate":"2025-10-27","conditions":"Gastroesophageal Reflux, Infant, Newborn, Diseases","enrollment":96},{"nctId":"NCT06975605","phase":"PHASE1","title":"Phase 1, Open-label, Drug-drug Interaction Study to Assess Effect Between Radiprodil and the Co-administered Drugs.","status":"COMPLETED","sponsor":"GRIN Therapeutics, Inc.","startDate":"2025-05-20","conditions":"Tuberous Sclerosis Complex (TSC), Focal Cortical Dysplasia, Other Neurological Disorders","enrollment":18},{"nctId":"NCT03866668","phase":"PHASE2","title":"A Study of Esomeprazole in Children With Autism","status":"RECRUITING","sponsor":"Stanford University","startDate":"2019-05-29","conditions":"Autism, Autism Spectrum Disorder","enrollment":25},{"nctId":"NCT05267613","phase":"PHASE3","title":"Endoscopic Evidence of Maintenance of Healing With Oral NEXIUM in Patients 1 to 11 Years Old With Erosive Esophagitis.","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2022-07-01","conditions":"Erosive Esophagitis","enrollment":50},{"nctId":"NCT07149415","phase":"PHASE1","title":"A Study to Learn if Taking BIIB141 (Omaveloxolone) Affects How Omeprazole is Processed in the Body and About BIIB141's Safety in Healthy Adults Aged 18 to 55","status":"COMPLETED","sponsor":"Biogen","startDate":"2025-09-02","conditions":"Healthy Volunteer","enrollment":22},{"nctId":"NCT06213818","phase":"PHASE1","title":"A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of INCB160058 When Administered Orally to Healthy Adult Participant","status":"COMPLETED","sponsor":"Incyte Corporation","startDate":"2024-03-14","conditions":"Healthy Participants","enrollment":137},{"nctId":"NCT04199624","phase":"PHASE1","title":"Assessment of Gastric pH Changes Induced by Ascorbic Acid Tablets","status":"COMPLETED","sponsor":"Indiana University","startDate":"2021-10-01","conditions":"Hypochlorhydria","enrollment":11},{"nctId":"NCT05468164","phase":"PHASE1","title":"A Study of Effect of Food and a Proton Pump Inhibitor on Selpercatinib (LY3527723) in Healthy Participants","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2018-05-31","conditions":"Healthy","enrollment":20},{"nctId":"NCT04394663","phase":"NA","title":"High Dose Oral Omeprazole in High Risk UGIB","status":"RECRUITING","sponsor":"King Chulalongkorn Memorial Hospital","startDate":"2020-10-01","conditions":"GI Bleeding","enrollment":128},{"nctId":"NCT02504554","phase":"PHASE1, PHASE2","title":"Beneficial Bacteria Treatment for Autism","status":"COMPLETED","sponsor":"Arizona State University","startDate":"2014-07","conditions":"Gastrointestinal Problems, Autism Spectrum Disorders","enrollment":18},{"nctId":"NCT06949124","phase":"PHASE1","title":"A Phase 1 Clinical Study to Evaluate the Effects of SHR7280 on the Pharmacokinetics of Midazolam, S-warfarin, Omeprazole, Digoxin, and Rosuvastatin in Healthy Subjects","status":"COMPLETED","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2025-04-28","conditions":"Endometriosis, Uterine Fibroids, Assisted Reproduction","enrollment":20},{"nctId":"NCT05741385","phase":"NA","title":"A Study to Compare How Different Substances (Caffeine, Warfarin, Omeprazole, Metoprolol, and Midazolam) Are Handled by the Body of Healthy People and People With Liver Cirrhosis","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2023-10-10","conditions":"Liver Cirrhosis","enrollment":4},{"nctId":"NCT05753774","phase":"NA","title":"Effect of Fecal Microbiota Transplantation (FMT) in Pediatric Functional Gastrointestinal Disorders","status":"RECRUITING","sponsor":"Biao Zou","startDate":"2022-08-01","conditions":"Functional Gastrointestinal Disorders","enrollment":100},{"nctId":"NCT05680870","phase":"PHASE3","title":"The Possible Protective Role of Omeprazole Against Oxaliplatin Induced Neuropathy in Cancer Patients","status":"COMPLETED","sponsor":"Aya Mohamed Sadek Elsaid","startDate":"2023-02-01","conditions":"Chemotherapy Induced Peripheral Neuropathy","enrollment":46},{"nctId":"NCT06383338","phase":"PHASE1","title":"A Study Investigating the Change in Metabolism Phenotype in Paediatric, Adolescent & Young Adults With Hodgkin or Non-Hodgkin Lymphoma.","status":"RECRUITING","sponsor":"Murdoch Childrens Research Institute","startDate":"2025-07-22","conditions":"Hodgkin Lymphoma, Non Hodgkin Lymphoma","enrollment":10},{"nctId":"NCT01188525","phase":"PHASE1","title":"Pharmacokinetic Study to Characterize Individual Metabolic Profile","status":"COMPLETED","sponsor":"Institut National de la Santé Et de la Recherche Médicale, France","startDate":"2010-08","conditions":"Healthy Volunteers","enrollment":10},{"nctId":"NCT07007806","phase":"PHASE1","title":"Drug-drug Interaction Study of Omeprazole and Bemnifosbuvir/Ruzasvir","status":"COMPLETED","sponsor":"Atea Pharmaceuticals, Inc.","startDate":"2025-05-09","conditions":"Healthy Volunteer Study","enrollment":20},{"nctId":"NCT07144657","phase":"PHASE2","title":"Prospective Study of Frontline Antibiotics Therapy in the Treatment of Early-stage HP-negative Gastric MALT Lymphoma","status":"NOT_YET_RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2025-09-01","conditions":"MALT Lymphoma of Stomach","enrollment":40},{"nctId":"NCT07138235","phase":"","title":"Complications of Laparoscopic Hiatal Hernia Repair Complicated by Gastroesophageal Reflux Disease Using the ERAS Protocol","status":"COMPLETED","sponsor":"Osh State University","startDate":"2016-10-01","conditions":"Hiatal Hernia, Hiatal Hernia With Gastroesophageal Reflux Disease","enrollment":106},{"nctId":"NCT03358706","phase":"PHASE1","title":"A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative Colitis","status":"TERMINATED","sponsor":"Janssen Research & Development, LLC","startDate":"2018-02-02","conditions":"Crohn Disease, Ulcerative Colitis","enrollment":28},{"nctId":"NCT04865731","phase":"PHASE2","title":"Dermaprazole Cream for Radiation Dermatitis in Head and Neck Cancer","status":"COMPLETED","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"2022-06-15","conditions":"Cancer of the Head and Neck","enrollment":6},{"nctId":"NCT06999577","phase":"PHASE4","title":"The Mechanism Versus PPI Trial","status":"RECRUITING","sponsor":"University of California, San Diego","startDate":"2025-06-04","conditions":"Laryngopharyngeal Reflux, Cough, Throat Clearing","enrollment":160},{"nctId":"NCT06917963","phase":"NA","title":"Study of Treatment With Intensified Omeprazole Treatment to Prevent High Output Stoma 1","status":"RECRUITING","sponsor":"Medical University of Gdansk","startDate":"2025-04-10","conditions":"Stoma - Ileostomy, High Output Stoma, Colon Cancer","enrollment":80},{"nctId":"NCT06861478","phase":"PHASE2","title":"PPIs and In-Hospital Morbidity in Acute Variceal Bleeding With Chronic Liver Disease","status":"RECRUITING","sponsor":"Universidad Autonoma de Nuevo Leon","startDate":"2024-10-20","conditions":"Morbidity","enrollment":182},{"nctId":"NCT07086937","phase":"NA","title":"Efficacy of Nitazoxanide Based Therapy vs Standard Triple Therapy in H-pylori in Children","status":"COMPLETED","sponsor":"Muhammad Aamir Latif","startDate":"2025-01-01","conditions":"Helicobacter Pylori Infection","enrollment":66},{"nctId":"NCT05070351","phase":"PHASE1, PHASE2","title":"Deprescribing Proton Pump Inhibitors to Reduce Post-TIPS Hepatic Encephalopathy","status":"COMPLETED","sponsor":"Duke University","startDate":"2022-01-03","conditions":"Hepatic Encephalopathy","enrollment":33},{"nctId":"NCT06948006","phase":"PHASE1","title":"A Study to Investigate the Relative Bioavailability of 2 Different Formulations of AZD4144, the Effect of Food and Omeprazole on the Pharmacokinetics of AZD4144 in Healthy Participants","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2025-04-23","conditions":"Healthy Participants","enrollment":32},{"nctId":"NCT06605950","phase":"PHASE1","title":"A Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of Xanomeline With Trospium Chloride Versus KarXT in Healthy Adult and Elderly Participants of Japanese Ethnicity and to Assess the Effect of Omeprazole on the PK of Xanomeline With Trospium Chloride in Healthy Adult Participants","status":"COMPLETED","sponsor":"Karuna Therapeutics, Inc., a Bristol Myers Squibb company","startDate":"2024-10-01","conditions":"Healthy Volunteers","enrollment":78},{"nctId":"NCT06514274","phase":"PHASE4","title":"Study on The Efficacy and Safety of Vonoprazan-containing Berberine Triple Therapy in Helicobacter Pylori First-Line Eradication","status":"COMPLETED","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2024-09-20","conditions":"Helicobacter Pylori Infection, Chronic Gastritis","enrollment":558},{"nctId":"NCT06523764","phase":"PHASE4","title":"Efficacy and Safety of Tegoprazan and Minocycline Dual Therapy for Helicobacter Pylori Initial Treatment","status":"ACTIVE_NOT_RECRUITING","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2024-11-11","conditions":"Helicobacter Pylori Infection Chronic Gastrit","enrollment":208},{"nctId":"NCT06168084","phase":"PHASE4","title":"Helicobacter Rescue Therapy With Vonorazon and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy","status":"COMPLETED","sponsor":"Yongquan Shi","startDate":"2023-06-06","conditions":"Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Cancer Peptic Ulcer","enrollment":688},{"nctId":"NCT05487235","phase":"PHASE1","title":"A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors","status":"COMPLETED","sponsor":"Genentech, Inc.","startDate":"2022-08-17","conditions":"Advanced Solid Tumors, Metastatic Solid Tumors","enrollment":57},{"nctId":"NCT05742568","phase":"PHASE4","title":"Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal Microecology","status":"COMPLETED","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2022-12-01","conditions":"Gastritis, Dyspepsia, Helicobacter Pylori Infection","enrollment":124},{"nctId":"NCT06690164","phase":"PHASE4","title":"Study on the Effect of Atorvastatin Co-administered With Omeprazole on Statin Lactone","status":"RECRUITING","sponsor":"National University Hospital, Singapore","startDate":"2025-06-12","conditions":"Metabolite","enrollment":78},{"nctId":"NCT07040839","phase":"PHASE4","title":"Comparison of Omeprazole vs Vonoprazon in Treatment of H Pylori Infection","status":"NOT_YET_RECRUITING","sponsor":"Rehman Medical Institute - RMI","startDate":"2025-07","conditions":"H Pylori","enrollment":128},{"nctId":"NCT07037888","phase":"PHASE4","title":"Efficacy of Ketorolac for Postoperative Pain Management in Hip Arthroscopy: A Prospective Double-Blinded Randomized Controlled Trial","status":"RECRUITING","sponsor":"Henry Ford Health System","startDate":"2023-12-13","conditions":"Femoracetabular Impingement, Hip Arthroscopy","enrollment":100},{"nctId":"NCT00001337","phase":"PHASE2","title":"Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"1993-05-08","conditions":"Diffuse Large B-Cell Lymphoma (DLBCL), Primary Mediastinal Large B-cell Lymphoma, Burkitt Lymphoma","enrollment":348},{"nctId":"NCT07021729","phase":"PHASE4","title":"Comparison of Two Treatment Regimens of Helicobacter Pylori Infection","status":"NOT_YET_RECRUITING","sponsor":"Rehman Medical Institute - RMI","startDate":"2025-12","conditions":"Helicobacter Pylori Infection","enrollment":156},{"nctId":"NCT06150898","phase":"PHASE2","title":"Ketorolac and Pregabalin Effects on breaSt Cancer (KePreSt)","status":"RECRUITING","sponsor":"Jules Bordet Institute","startDate":"2025-05-12","conditions":"Early-stage Breast Cancer, Estrogen-receptor-positive Breast Cancer","enrollment":112},{"nctId":"NCT06955520","phase":"NA","title":"Vonaprazan Versus Esomeprazole for Healing of LA Grade B or Higher Esophagitis After POEM","status":"RECRUITING","sponsor":"Asian Institute of Gastroenterology, India","startDate":"2025-04-30","conditions":"GERD","enrollment":300},{"nctId":"NCT07016737","phase":"PHASE3","title":"Immunochemotherapy ± Salvage Chemoradiation for Local Recurrence of Esophageal Squamous Cell Carcinoma After Definitive Chemoradiotherapy","status":"ENROLLING_BY_INVITATION","sponsor":"Ye jinjun","startDate":"2024-08-01","conditions":"Esophageal Squamous Cell Carcinoma (ESCC)","enrollment":79},{"nctId":"NCT06959368","phase":"PHASE4","title":"Vonoprazan Evaluation Compared to Standard Triple Therapy in Helicobacter Pylori eRadication","status":"RECRUITING","sponsor":"Asian Institute of Gastroenterology, India","startDate":"2025-03-25","conditions":"Helicobacter Pylori Infection","enrollment":484},{"nctId":"NCT07014930","phase":"PHASE1","title":"Identification of New Tools for Predicting Natural Metabolic Performance of the Liver","status":"RECRUITING","sponsor":"Caroline Samer","startDate":"2024-12-05","conditions":"Healthy Volunteers","enrollment":40},{"nctId":"NCT06279234","phase":"PHASE1","title":"A Study to Learn How Different Amounts of PF-06954522 Are Tolerated and Act in Adults With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Pfizer","startDate":"2024-02-20","conditions":"Type 2 Diabetes Mellitus (T2DM), Obesity","enrollment":50},{"nctId":"NCT06359015","phase":"PHASE4","title":"Metformin and Esomeprazole in Preterm Pre-eclampsia","status":"TERMINATED","sponsor":"Christiana Care Health Services","startDate":"2021-02-11","conditions":"Preeclampsia Severe, Pre-Eclampsia, Preeclampsia","enrollment":4},{"nctId":"NCT04720781","phase":"NA","title":"The Need of Revisiting to an Outpatient Clinic After the Prescription of Vonoprazan or Esomeprazole","status":"COMPLETED","sponsor":"Showa Inan General Hospital","startDate":"2021-01-21","conditions":"Gastroesophageal Reflux","enrollment":300},{"nctId":"NCT06973889","phase":"PHASE2","title":"Evaluation of IgY Antibody Efficacy in Egg Yolk Against Helicobacter Pylori in Bacterial Elimination and Clinical Symptoms Improvement of Gastrointestinal Patients","status":"COMPLETED","sponsor":"Mashhad University of Medical Sciences","startDate":"2023-12-04","conditions":"HELICOBACTER PYLORI INFECTIONS, Gastrointestinal Disease","enrollment":60},{"nctId":"NCT06966856","phase":"PHASE3","title":"This Randomized, Clinical Trial Evaluates the Efficacy of Oral Versus Sublingual Vitamin B12 Supplementation in Correcting Early-onset Vitamin B12 Deficiency in Adult Patients Using Proton Pump Inhibitors (PPIs). The Primary Outcome is the Change in Serum Vitamin B12 Levels Over a 6-week","status":"NOT_YET_RECRUITING","sponsor":"Tanta University","startDate":"2026-12-30","conditions":"Hypovitaminosis b 12","enrollment":23},{"nctId":"NCT00357682","phase":"PHASE3","title":"A Phase III, Randomized, Study of Aspirin and Esomeprazole Chemoprevention in Barrett's Metaplasia","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2005-03-10","conditions":"Esophageal Cancer, Precancerous Condition","enrollment":2557},{"nctId":"NCT03547024","phase":"PHASE1","title":"A Study in Healthy Participants to Evaluate the Effects of Multiple Doses of JNJ-55308942 on Cytochrome P450 Substrate Activity and on the Pharmacokinetics of Levonorgestrel/Ethinyl Estradiol","status":"COMPLETED","sponsor":"Janssen-Cilag International NV","startDate":"2018-06-08","conditions":"Healthy","enrollment":14},{"nctId":"NCT04448028","phase":"PHASE4","title":"Stop of Proton-pump Inhibitor Treatment in Patients With Liver Cirrhosis - a Double-blind, Placebo-controlled Trial","status":"RECRUITING","sponsor":"Universitätsklinikum Hamburg-Eppendorf","startDate":"2021-04-22","conditions":"Liver Cirrhosis","enrollment":476}],"_emaApprovals":[],"_faersSignals":[{"count":517,"reaction":"DYSPNOEA"},{"count":515,"reaction":"NAUSEA"},{"count":495,"reaction":"DRUG INTERACTION"},{"count":493,"reaction":"DIARRHOEA"},{"count":471,"reaction":"FATIGUE"},{"count":429,"reaction":"DIZZINESS"},{"count":369,"reaction":"PYREXIA"},{"count":366,"reaction":"VOMITING"},{"count":351,"reaction":"HEADACHE"},{"count":344,"reaction":"ANAEMIA"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Gastroenterology"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Omeprazol","genericName":"Omeprazol","companyName":"RenJi Hospital","companyId":"renji-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":1,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}